Darling Julianne O, Raheem Farah, Carter Katelyn C, Ledbetter Elizabeth, Lowe Jennifer F, Lowe Christopher
Health Simon Cancer Center, Indiana University, Indianapolis, IN 46202, USA.
Pharmacy (Basel). 2020 Mar 20;8(1):46. doi: 10.3390/pharmacy8010046.
Oral chemotherapy represents a major patient-centric advancement in therapy convenience. However, ownership of safe and correct administration of these agents requires significant patient education. To address this challenge, an in-person pharmacist-led oral chemotherapy education clinic in gastrointestinal oncology patients within an academic medical center was created and assessed. In this pilot program, a medication-specific quiz was administered to patients before and after education performed by a pharmacist to assess patient understanding of their new oral chemotherapy. A five-question satisfaction survey was also administered at the conclusion of the pharmacist clinic visit. Primary outcome was the percentage difference between pre-and post-education quiz scores. Secondary outcomes included patient satisfaction, time to treatment initiation, and number of pharmacist interventions. Frequencies and medians were used to describe categorical and continuous variables, respectively. Of the 18 patients analyzed, 50% were male and median age was 59.5 years. Approximately 28% had colon cancer, and 61% were treated with capecitabine. The median post-education scores improved from a pre-education score of 75% to 100%. Overall, seventeen of the eighteen patients responded with "strongly agree" to all satisfaction survey statements. An in-person oncology pharmacist-led oral chemotherapy education session demonstrated an improvement in patients' understanding of their new oral chemotherapy treatment.
口服化疗代表了以患者为中心在治疗便利性方面的一项重大进展。然而，确保这些药物安全正确使用需要对患者进行大量教育。为应对这一挑战，在一家学术医疗中心设立并评估了一个由药剂师亲自指导的针对胃肠道肿瘤患者的口服化疗教育诊所。在这个试点项目中，在药剂师进行教育前后，对患者进行了特定药物的测验，以评估患者对新口服化疗药物的理解。在药剂师门诊结束时还进行了一项包含五个问题的满意度调查。主要结果是教育前后测验分数的百分比差异。次要结果包括患者满意度、开始治疗的时间以及药剂师干预的次数。频率和中位数分别用于描述分类变量和连续变量。在分析的18名患者中，50%为男性，年龄中位数为59.5岁。约28%患有结肠癌，61%接受了卡培他滨治疗。教育后的分数中位数从教育前的75%提高到了100%。总体而言，18名患者中有17名对所有满意度调查陈述回答“强烈同意”。由肿瘤药剂师亲自指导的口服化疗教育课程表明患者对新口服化疗治疗的理解有所提高。
